We are live on ! Find out more
CRHM

CRH Medical Corporation
CRHM

Delisted

CRHM was delisted on the 22nd of April, 2021.

42 hedge funds and large institutions have $120M invested in CRH Medical Corporation in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

17% more funds holding

Funds holding: 3642 (+6)

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

15% more capital invested

Capital invested by funds: $105M → $120M (+$15.3M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
42
Holders Change
+6
Holders Change %
+16.67%
% of All Funds
0.83%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
7
Increased
15
Reduced
13
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$22.6M
SCM
2
Stadium Capital Management
Connecticut
$16.9M -$368K -116,506 -2%
BGC
3
Beutel, Goodman & Co
Ontario, Canada
$15.2M -$519K -164,500 -4%
Morgan Stanley
4
Morgan Stanley
New York
$12.8M -$767K -242,845 -6%
PRCP
5
Pacific Ridge Capital Partners
Oregon
$8.82M +$353K +111,917 +5%
Stifel Financial
6
Stifel Financial
Missouri
$7.62M -$21.6K -6,830 -0.3%
Connor, Clark & Lunn Investment Management (CC&L)
7
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$7.46M +$87.7K +27,800 +1%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$7.27M +$147K +46,646 +2%
Goldman Sachs
9
Goldman Sachs
New York
$5.31M +$169K +53,511 +4%
JP Morgan Chase
10
JP Morgan Chase
New York
$3.94M +$169K +53,700 +5%
Renaissance Technologies
11
Renaissance Technologies
New York
$3.2M +$748K +236,823 +35%
RA
12
Royce & Associates
New York
$1.65M
PP
13
Palladium Partners
Virginia
$1.21M +$445K +141,000 +68%
HIM
14
Hillsdale Investment Management
Ontario, Canada
$1.09M +$509K +161,200 +105%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$861K -$17.7K -5,600 -2%
PPW
16
Parcion Private Wealth
Washington
$809K +$735K +233,000 New
CAM
17
Claret Asset Management
Quebec, Canada
$572K +$4.76K +1,508 +0.9%
SCP
18
Seizert Capital Partners
Michigan
$521K -$24.7K -7,822 -5%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$349K +$312K +98,981 +6,599%
WCM
20
Wedge Capital Management
North Carolina
$328K -$11.6K -3,679 -4%
CP
21
Cumberland Partners
Ontario, Canada
$269K +$244K +77,400 New
TD Asset Management
22
TD Asset Management
Ontario, Canada
$217K -$1.72K -544 -0.9%
QC
23
Quadrature Capital
United Kingdom
$216K +$198K +62,800 New
QI
24
QS Investors
New York
$213K +$44.2K +14,000 +30%
Bank of America
25
Bank of America
North Carolina
$207K +$23.4K +7,422 +14%

CRHM Hedge Fund Activity: Q4 2019 in Review

42 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in CRH Medical Corporation (CRHM) for Q4 2019, worth a combined $120M — up 15% from $105M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CRHM positions and 1 closed out — a net gain of 6 holders — while 15 added to existing stakes and 13 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $748K. The largest seller was Morgan Stanley, cutting an estimated $767K.

  • 42 institutional investors held CRH Medical Corporation (CRHM) as of Q4 2019, up from 36 in Q3 2019.
  • Funds reported $120M of CRH Medical Corporation stock for Q4 2019, up 15% quarter-over-quarter.
  • 7 funds opened new CRH Medical Corporation positions in Q4 2019 and 1 closed out, a net change of +6 holders.
  • The largest CRH Medical Corporation buyer in Q4 2019 was Renaissance Technologies, an estimated $748K added.
  • The largest CRH Medical Corporation seller in Q4 2019 was Morgan Stanley, an estimated $767K sold.

Based on aggregated 13F filings for Q4 2019.